↓ Skip to main content

One step forward, one step sideways? Expanding research capacity for neglected diseases

Overview of attention for article published in BMC Public Health, July 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

blogs
1 blog
facebook
1 Facebook page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
One step forward, one step sideways? Expanding research capacity for neglected diseases
Published in
BMC Public Health, July 2010
DOI 10.1186/1472-698x-10-20
Pubmed ID
Authors

Joel Lexchin

Abstract

There is general agreement, including from the pharmaceutical industry, that current market based methods of generating research into the development of pharmaceutical products that are relevant for developing countries do not work. This conclusion is relevant not just for the most neglected diseases such as leishmaniasis but even for global diseases such as cancer and cardiovascular disease.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Mexico 1 1%
Sierra Leone 1 1%
United States 1 1%
Unknown 73 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 19%
Researcher 13 17%
Student > Ph. D. Student 9 12%
Student > Bachelor 8 10%
Student > Doctoral Student 4 5%
Other 11 14%
Unknown 17 22%
Readers by discipline Count As %
Social Sciences 18 23%
Medicine and Dentistry 14 18%
Agricultural and Biological Sciences 5 6%
Economics, Econometrics and Finance 5 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Other 13 17%
Unknown 18 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2014.
All research outputs
#6,495,301
of 25,371,288 outputs
Outputs from BMC Public Health
#6,927
of 17,508 outputs
Outputs of similar age
#30,632
of 104,864 outputs
Outputs of similar age from BMC Public Health
#34
of 91 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 17,508 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 104,864 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.